Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes

Inclusion Criteria: * Signed Informed Consent * Subjects with Dyslipidemia and Type II Diabetes * 6.5% ≤ HbA1c level ≤ 9.0% and LDL-C level ≤ 250mg/dL(6.5 nmal/L) at screening * BMI ≤ 45kg/m2 * Subjects who dose not administered diabetes treatment at least 4 weeks prior to screening visit. * 19 years later, men and women under the age of 75 Exclusion Criteria: * Pregnant women, nursing mothers or subject who does not agree to assigned contraception in the study * Subject with type I Diabetes * Subject with hypertension which does not controlled by treatment(have blood pressure \> 160/110mmHg) * Have a known allergy to drugs * Have administered Cyclosporine * Have administered Obesity treatment within 12 weeks prior to screening visit * Participated in any other clinical trials within 30 days prior to the first administration * Subject who is judged to be ineligible by investigator